HP1328 是FLT3受体酪氨酸激酶 (FLT3/ITD 突变) 的有效抑制剂。HP1328 是一种基于苯并咪唑支架的化合物。HP1328 显着降低白血病负担并延长 FLT3/ITD 白血病小鼠的生存期。
产品描述
HP1328 is a potent inhibitor of FLT3 receptor tyrosine kinase (FLT3/ITD mutation). HP1328 is a benzoimidazole scaffold-based compound. HP1328 significantly reduces the leukemia burden and prolongs the survival of mice with FLT3/ITD leukemia [1].
Cas No.
2245074-20-6
分子式
C23H23N3O3
分子量
389.45
储存和溶解度
(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
